Clin Infect Dis. 2023 Jul 25;77(Suppl 2):S211-S213. doi: 10.1093/cid/ciad325.
ABSTRACT
The AMR Diagnostics Use Accelerator Program was established to address antimicrobial resistance. Here, we bring into broad perspective the findings and missed opportunities of the first phase of the program and look toward the second phase.
PMID:37490737 | PMC:PMC10368406 | DOI:10.1093/cid/ciad325